BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 01, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

MUC1 serum immunoassay: Pilot trial data

Data from serum samples of 68 patients who had pancreatic cancer surgery and 19 healthy volunteers showed that the MUC1 immunoassay detected all stages of pancreatic cancer with 81% sensitivity and...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >